Cyclopentadienyldifluorphosphin und Homologe als Liganden in cis-Dichloroplatin(II)-Komplexen ― Struktur von cis-(C₅Me₅PF₂)₂PtCl₂ und cis-(C₉H₇PF₂)[(C₉H₇)₃P]PtCl₂ (C₅Me₅=Pentamethylcyclopentadienyl, C₉H₇-Indenyl) = Cyclopentadienyldifluorophosphine and its homologues as ligands in eis-dichloroplatinum(II) complexes. Structure of cis-(C₅Me₅PF₂)₂PtCl₂ and cis-(C₉H₇PF₂)[(C₉H₇)₃P]PtCl₂ (C₅Me₅=pentamethylcyclopentadienyl, C₉H₇=indenyl)HEUER, L; BODE, U. K; JONES, P. G et al.Zeitschrift für Naturforschung. B, A journal of chemical sciences. 1989, Vol 44, Num 9, pp 1082-1092, issn 0932-0776, 11 p.Article

Circadian time-dependent tissue uptake of cisplatin (CDDP) and carboplatin (CBDCA) following repeated administrations : relationship with drug toxicities in miceBOUGHATTAS, N. A; FOURNIER, C; HECQUET, B et al.Annual review of chronopharmacology. 1990, Vol 7, pp 231-234, issn 0743-9539, 4 p.Conference Paper

Composés du Pt(II) à visée antitumorale, dérivés de l'ellipticine et de ses analogues = Antitumoral compounds of Pt(II), derivatives of ellipticine and its analoguesBENAZETH, S; BAZIN, D; VIOSSAT, B et al.Journal de chimie physique. 1989, Vol 86, Num 7-8, pp 1635-1642, issn 0021-7689, 8 p.Article

Platinum complexes of p- and m-aminobenzamidine. Synthesis, characterization, and cytotoxic activityNAVARRO-RANNINGER, C; AMO OCHOA, P; PEREZ, J. M et al.Journal of inorganic biochemistry. 1992, Vol 48, Num 3, pp 163-171, issn 0162-0134Article

Site-specifically platinated DNA, a new probe of the biological activity of platinum anticancer drugsPINTO, A. L; NASER, L. J; ESSIGMANN, J. M et al.Journal of the American Chemical Society. 1986, Vol 108, Num 23, pp 7405-7407, issn 0002-7863Article

Synthesis of bis(phosphine)-1,2-dihydroplatina(II)cyclobutabenzenes. Molecular structure of the 1,2-dihydroplatina(II) cyclobutabenzene Pt(CH₂-o-C₆H₄)(PMe₃)₂DE BOER, H. J. R; SCHAT, G; AKKERMAN, O. S et al.Organometallics. 1989, Vol 8, Num 5, pp 1288-1291, issn 0276-7333, 4 p.Article

Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic ExposureSCHMITT, Antonin; GLADIEFF, Laurence; PINGUET, Frédéric et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4568-4574, issn 0732-183X, 7 p.Article

Oxaliplatin-induced immune pancytopeniaTALEGHANI, Behrouz Mansouri; FONTANA, Stefano; MEYER, Oliver et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 5, pp 704-708, issn 0041-1132, 5 p.Article

CisplatinMEENAKSHI DABHOLKAR; CHRISTIAN, M; REED, E et al.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 87-98, issn 0921-4410Article

General pharmacology of cis-malonato [(4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3-dioxalone]platinum(II)KIM, D.-K; AHN, J. S; RUY, G et al.Arzneimittel-Forschung. 1994, Vol 44, Num 9, pp 1080-1088, issn 0004-4172Article

NMR studies of an oligonucleotide with an unusual structure induced by platinum anti cancer drugsKLINE, T. P; MARZILLI, L. G; LIVE, D et al.Biochemical pharmacology. 1990, Vol 40, Num 1, pp 97-113, issn 0006-2952, 17 p.Conference Paper

Supplemental fosfomycin and/or steroids that reduce cisplatin-induced nephrotoxicityUMEKI, S; WATANABE, M; YAGI, S et al.The American journal of the medical sciences. 1988, Vol 295, Num 1, pp 6-10, issn 0002-9629Article

Tumor responsiveness of squamous cell carcinoma to cisplatinVALYI-NAGY, K; HALE, P. E; QUINN, F. B et al.The Laryngoscope. 1986, Vol 96, Num 7, pp 758-762, issn 0023-852XArticle

Molecular-wire behavior of OLED materials : Exciton dynamics in multichromophoric alq₃-oligofluorene-Pt(II)porphyrin triadsMONTES, Victor A; PEREZ-BOLIVAR, César; AGARWAL, Neeraj et al.Journal of the American Chemical Society. 2006, Vol 128, Num 38, pp 12436-12438, issn 0002-7863, 3 p.Article

Allergic reactions to carboplatinHENDRICK, A. M; SIMMONS, D; CANTWELL, B. M. J et al.Annals of oncology. 1992, Vol 3, Num 3, pp 239-240, issn 0923-7534Article

Resistance to platinum compounds: mechanisms and beyondKELLEY, S. L; ROZENCWEIG, M.European journal of cancer & clinical oncology. 1989, Vol 25, Num 8, pp 1135-1140, issn 0277-5379Article

The crystal structure of potassium tetraiodoplatinate(II) dihydrateOLSSON, L.-F; OSKARSSON, A.Acta chemica scandinavica (1989). 1989, Vol 43, Num 8, pp 811-812, 2 p.Article

Prospective nerve conduction studies in cisplatin therapyRIGGS, J. E; MOHAMMED ASHRAF; SNYDER, R. D et al.Annals of neurology. 1988, Vol 23, Num 1, pp 92-94, issn 0364-5134Article

Mécanisme d'activation des alcanes, des arènes et de l'hydrogène dans les solutions aqueuses d'halogénures de platine(II)RUDAKOV, E. S.Žurnal fizičeskoj himii. 1987, Vol 61, Num 2, pp 289-301, issn 0044-4537Article

Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodiesSUNDQUIST, W. I; LIPPARD, S. J; STOLLAR, B. D et al.Biochemistry (Easton). 1986, Vol 25, Num 7, pp 1520-1524, issn 0006-2960Article

Spectroscopic evidence for stacking and electrostatic interactions between nucleoside 5'-monophosphates and a platinum DNA intercalator, (2,2'-bipyridine)(ethylenediamine)platinum(II), in dilute aqueous solutionYAMAUCHI, O; ODANI, A; SHIMATA, R et al.Inorganic chemistry (Print). 1986, Vol 25, Num 19, pp 3337-3339, issn 0020-1669Article

Studies on the interaction between antitrypanosome cis-DDP analogs with DNALOPEZ, M. C; RUIZ, L. M; CRACIUNESCU, D et al.Chemico-biological interactions. 1986, Vol 59, Num 1, pp 99-111, issn 0009-2797Article

Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine WastingLANCASTER, Cynthia S; CHAOXIN HU; FRANKE, Ryan M et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4789-4799, issn 1078-0432, 11 p.Article

Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorptionARNDT, Patricia; GARRATTY, George; ISAAK, Edahn et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 4, pp 711-718, issn 0041-1132, 8 p.Article

Modulation of cis-diamminedichloroplatinum(II) resistance : a reviewTIMMER-BOSSCHA, H; MULDER, N. H; DE VRIES, E. G. E et al.British journal of cancer. 1992, Vol 66, Num 2, pp 227-238, issn 0007-0920Article